News
Why US-EU trade deal faces jeopardy over ambiguous pharmaceutical tariffs
Pharmaceutical companies are seeking clarification on tariffs imposed under the new US-EU trade agreement . Analysts caution that sector-specific punitive levies could jeopardise the entire deal, according to a CNBC report.
The benchmark STOXX 600 rose 0.9% to hit a four-month high early in Monday's session but reversed course to close about 0.2% ...
Jeep owner Stellantis said on Monday it suffered a massive loss in the first half of the year, when it felt the first impact ...
A threatened 30% tariff on European wines would hurt many U.S. companies while hiking prices at home and in restaurants, ...
Stellantis said on Tuesday it faced greater headwinds this year including a 1.5-billion-euro impact from U.S. tariffs for ...
Despite being significantly lower than the 200% rate threatened by Trump, the deal is set to ramp up drug costs by billions.
Tuko on MSN2h
Philips chops back US tariff billDutch medical equipment manufacturer Philips said Tuesday that the impact of US tariffs would be much less than it initially estimated, sending its share price surging.It said Tuesday it now expects ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback